ArticlePharmaceuticals (Basel, Switzerland)2024

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database.

Giuseppe Cicala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.